Literature DB >> 21817125

No evidence for human papillomavirus in the etiology of colorectal polyps.

Andrea N Burnett-Hartman1, Polly A Newcomb, Margaret T Mandelson, Denise A Galloway, Margaret M Madeleine, Michelle A Wurscher, Joseph J Carter, Karen W Makar, John D Potter, Stephen M Schwartz.   

Abstract

BACKGROUND: While some studies have reported detection of oncogenic human papillomavirus (HPV) in colorectal tumors, others have not.
METHODS: We examined the association between oncogenic HPV infection and colorectal polyps in a case-control study of individuals with colorectal adenomas (n = 167), hyperplastic polyps (n = 87), and polyp-free controls (n = 250). We carried out real-time PCR for HPV-16 and -18 DNA, and SPF PCR covering 43 HPV types, on lesional and normal colorectal tissue samples. Plasma antibodies for oncogenic HPV types were assessed via a bead-based multiplex Luminex assay.
RESULTS: HPV DNA was not found in any of the 609 successfully assayed colorectal tissue samples from adenomas, hyperplastic polyps, normal biopsies adjacent to polyps, or normal biopsies of the rectum of disease-free controls. Also, there was no association between HPV seropositivity for all oncogenic HPV types combined, for either polyp type, and for men or women. When analyses were restricted to participants without a history of polyps, among men [adenomas (n = 31), hyperplastic polyps (n = 28), and controls (n = 68)], there was an association between seropositivity and hyperplastic polyps when all oncogenic HPV types were combined (OR = 3.0; 95% CI: 1.1-7.9).
CONCLUSIONS: Overall, our findings do not support an etiologic relationship between HPV and colorectal adenomas or hyperplastic polyps; however, our finding suggesting an association between HPV seropositivity and hyperplastic polyps in men may warrant further investigations. IMPACT: After stringent controls for contamination and three methods to assess HPV infection, we report no evidence for HPV in the etiology of colorectal neoplasia for either men or women. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21817125      PMCID: PMC3236024          DOI: 10.1158/1055-9965.EPI-11-0450

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  50 in total

1.  Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.

Authors:  J J Carter; L A Koutsky; J P Hughes; S K Lee; J Kuypers; N Kiviat; D A Galloway
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

Review 2.  Human papillomavirus and cancer: the epidemiological evidence.

Authors:  N Muñoz
Journal:  J Clin Virol       Date:  2000-10       Impact factor: 3.168

3.  Seroprevalence of human papillomavirus type 16 infection in the United States.

Authors:  Katherine M Stone; Kevin L Karem; Maya R Sternberg; Geraldine M McQuillan; Alysia D Poon; Elizabeth R Unger; William C Reeves
Journal:  J Infect Dis       Date:  2002-10-21       Impact factor: 5.226

4.  Human papillomavirus type 18 in colorectal cancer.

Authors:  Y M Lee; S Y Leu; H Chiang; C P Fung; W T Liu
Journal:  J Microbiol Immunol Infect       Date:  2001-06       Impact factor: 4.399

5.  Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?

Authors:  Libby M Morimoto; Polly A Newcomb; Cornelia M Ulrich; Roberd M Bostick; Cynthia J Lais; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

6.  Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps.

Authors:  Scott V Adams; Polly A Newcomb; Andrea N Burnett-Hartman; Emily White; Margaret T Mandelson; John D Potter
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

7.  Hyperplastic polyposis: association with colorectal cancer.

Authors:  B A Leggett; B Devereaux; K Biden; J Searle; J Young; J Jass
Journal:  Am J Surg Pathol       Date:  2001-02       Impact factor: 6.394

8.  Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.

Authors:  J J Carter; M M Madeleine; K Shera; S M Schwartz; K L Cushing-Haugen; G C Wipf; P Porter; J R Daling; J K McDougall; D A Galloway
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

10.  Natural history of human papillomavirus type 16 virus-like particle antibodies in young women.

Authors:  Gloria Y F Ho; Yevgeniy Y Studentsov; Robert Bierman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

View more
  16 in total

1.  Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population.

Authors:  Ruhina S Laskar; Fazlur R Talukdar; Javed H Choudhury; Seram Anil Singh; Sharbadeb Kundu; Bishal Dhar; Rosy Mondal; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2015-02-03

2.  No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Stephen M Schwartz; Roberd M Bostick; Michael Pawlita; Tim Waterboer; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-26       Impact factor: 4.254

3.  Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Amanda I Phipps; Michael N Passarelli; William M Grady; Melissa P Upton; Lee-Ching Zhu; John D Potter
Journal:  Am J Gastroenterol       Date:  2012-06-12       Impact factor: 10.864

4.  Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.

Authors:  Danny V Colombara; James P Hughes; Andrea N Burnett-Hartman; Stephen E Hawes; Denise A Galloway; Stephen M Schwartz; Roberd M Bostick; John D Potter; Lisa E Manhart
Journal:  J Immunol Methods       Date:  2015-06-11       Impact factor: 2.303

5.  Human papillomavirus does not have a causal role in colorectal carcinogenesis.

Authors:  Laura Lorenzon; Francesca Mazzetta; Emanuela Pilozzi; Giordana Uggeri; Maria Rosaria Torrisi; Mario Ferri; Vincenzo Ziparo; Deborah French
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

7.  Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter; Michael N Passarelli; Amanda I Phipps; Michelle A Wurscher; William M Grady; Lee-Ching Zhu; Melissa P Upton; Karen W Makar
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

8.  Potential role of human papilloma virus in the pathogenesis of gastric cancer.

Authors:  Miroslaw Snietura; Dariusz Waniczek; Wojciech Piglowski; Agnieszka Kopec; Ewa Nowakowska-Zajdel; Zbigniew Lorenc; Malgorzata Muc-Wierzgon
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 9.  Human papillomavirus and colorectal cancer.

Authors:  Marina K Ibragimova; Matvey M Tsyganov; Nicolay V Litviakov
Journal:  Med Oncol       Date:  2018-09-05       Impact factor: 3.064

10.  Significance of infectious agents in colorectal cancer development.

Authors:  Vlado Antonic; Alexander Stojadinovic; Kent E Kester; Peter J Weina; Björn Ldm Brücher; Mladjan Protic; Itzhak Avital; Mina Izadjoo
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.